Brain Receptor Methodologies - 1st Edition - ISBN: 9780124703520, 9781483269597

Brain Receptor Methodologies

1st Edition

Amino Acids. Peptides. Psychoactive Drugs

Editors: Paul J. Marangos Iain C. Campbell Robert M. Cohen
eBook ISBN: 9781483269597
Imprint: Academic Press
Published Date: 28th January 1984
Page Count: 356
Sales tax will be calculated at check-out Price includes VAT/GST
25% off
25% off
25% off
25% off
25% off
20% off
20% off
25% off
25% off
25% off
25% off
25% off
20% off
20% off
25% off
25% off
25% off
25% off
25% off
20% off
20% off
54.95
41.21
41.21
41.21
41.21
41.21
43.96
43.96
43.99
32.99
32.99
32.99
32.99
32.99
35.19
35.19
72.95
54.71
54.71
54.71
54.71
54.71
58.36
58.36
Unavailable
Price includes VAT/GST
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Brain Receptor Methodologies: Part B Amino Acids. Peptides. Psychoactive Drugs is the second of the two-part first volume of the Neurobiological Research series, which provides a comprehensive view of various subdisciplines within neurobiology. The first volume (Parts A and B) deals with the area of neurotransmitter and neuromodulator receptors in brain; future volumes will cover the subdisciplines of neuroanatomy, neurophysiology, brain-specific macromolecules, neurochemistry, and behavioral neurobiology. It is hoped that the series will be of equal value for both basic as well as clinical scientists Part B continues from Part A with the remainder of Section II, specific receptor binding methodologies. Subsection II,B deals with receptors for amino acids and neuropeptides and covers areas including GABA, glycine, carnosine, opiates, bombesin, CCK, TRH, and substance P. Amino acids probably represent the majority of brain neurotransmitter substances, at least relative to the amines and acetylcholine, although with the exception of GABA, the amino acids remain relatively uncharacterized in brain. Their further study should receive high priority.

Table of Contents


Contributors

General Preface

Preface to Part B

Contents of Part A

Section II Specific Receptor-Binding Methodologies

B. Amino Acids and Peptides

1. GABA Receptors in the Vertebrate eNS

2. Glycine Receptors in the Nervous System

3. Identification and Characterization of a Carnosine Binding Site

4. Opiate Receptors: Current Issues and Methodologies

5. Receptors for Bombesin-Like Peptides

6. Central and Peripheral CCK Receptors

7. Pituitary and CNS TRH Receptors

8. Peripheral and Central Substance P Binding Sites

C. Psychoactive Drugs

9. The Benzodiazepine Receptor

10. Benzodiazepine-GABA Receptor Interactions

11. Picrotoxinin Binding Sites in Brain

12. Phencyclidine Receptors in Brain: Current Methodological Issues

13. Neuroleptic Binding Sites in Brain

14. High-Affinity Binding Sites for Tricyclic Antidepressants in Brain and Platelets

15. Adenosine: Its Action and Sites of Action in the CNS

Index

Details

No. of pages:
356
Language:
English
Copyright:
© Academic Press 1984
Published:
Imprint:
Academic Press
eBook ISBN:
9781483269597

About the Editor

Paul J. Marangos

Dr. Marangos is author of 252 peer-reviewed research papers on neurobiology, and 4 books – three by Academic Press (the Neurobiological Research series of volumes) and a fourth titled “Emerging Strategies in Neuroprotection”. He is a founding editor of “The Journal of Molecular Neuroscience” and inventor on 14 issued patents. He spent 13 years at the NIMH and was adjunct professor of neurochemistry at GW School of Medicine during that time. He is co-Founder of five Biotech firms with over 20 years of experience as CEO of both public and private life science companies. He has had extensive experience in all aspects of the pharmaceutical and biotechnology industries from bench to product. This coupled with his academic experience has provided a global perspective on the entire medical R&D enterprise, in particular its faults, and remedies to speed the quest for cures.

Affiliations and Expertise

UCSD CONNECT Springboard Entrepreneurs Program

Iain C. Campbell

Robert M. Cohen

Ratings and Reviews